In a major consolidation move in the Indian pharmaceutical sector, Torrent Pharmaceuticals Limited (“Torrent” or “Acquirer”) has announced the acquisition of a 46.39% controlling stake in J.B. Chemicals and Pharmaceuticals Limited (“JB” or “Target”) from global investment firm KKR, followed by a proposed merger of JB into Torrent. This strategic transaction marks one of the largest domestic pharma deals in recent year...
Already a user? Sign in



